OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study

Abstract

This study confirmed the effectiveness of treatment with OnabotulinumtoxinA after 1 year of treatment. The chances of a good outcome may be increased by starting treatment in the first 12 months after chronic migraine diagnosis.